Defective membrane fusion and repair in Anoctamin5-deficient muscular dystrophy

Human Molecular Genetics

Volumn 25, Issue 10, 2016, Pages 1900-1911

  Griffin, Danielle A ^a   Johnson, Ryan W ^a   Whitlock, Jarred M ^d   Pozsgai, Eric R ^a,c   Heller, Kristin N ^a   Grose, William E ^a   Arnold, W David ^b   Sahenk, Zarife ^a,b   Hartzell, H Criss ^d   Rodino Klapac, Louise R ^a,b,c  

^a THE RESEARCH INSTITUTE AT NATIONWIDE CHILDREN S HOSPITAL   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^d EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOTOXIN; ANO5 PROTEIN, HUMAN; CHLORIDE CHANNEL;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANOCTAMIN 5 GENE; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; EMBRYO; GENE DISRUPTION; HISTOPATHOLOGY; HUMAN; INFANT; KNOCKOUT MOUSE; LIMB GIRDLE MUSCULAR DYSTROPHY; LIMB GIRDLE MUSCULAR DYSTROPHY TYPE 2L; MEMBRANE FUSION; MOUSE; MULTINUCLEAR CELL; MUSCLE REGENERATION; MUSCULAR DYSTROPHY; MUTATOR GENE; MYOBLAST; MYOTUBE; NONHUMAN; PRIORITY JOURNAL; SARCOLEMMA; ANIMAL; DISEASE MODEL; DISTAL MYOPATHY; GENETICS; MUSCLE ATROPHY; MUTATION; PATHOLOGY; SKELETAL MUSCLE; SKELETAL MUSCLE CELL;

ANIMALS; CHLORIDE CHANNELS; DISEASE MODELS, ANIMAL; DISTAL MYOPATHIES; HUMANS; MICE; MICE, KNOCKOUT; MUSCLE FIBERS, SKELETAL; MUSCLE, SKELETAL; MUSCULAR ATROPHY; MUSCULAR DYSTROPHIES, LIMB-GIRDLE; MUTATION; SARCOLEMMA;

EID: 84992170348     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddw063     Document Type: Article

References (60)

1. Guiraud, S., Aartsma-Rus, A., Vieira, N.M., Davies, K.E., van Ommen, G.J. and Kunkel, L.M. (2015) The pathogenesis and therapy of muscular dystrophies. Annu. Rev. Genomics Hum. Genet., 16, 281-308.
2. Constantin, B. (2014) Dystrophin complex functions as a scaffold for signaling proteins. Biochim. Biophys. Acta, 1838, 635-642.
3. Lapidos, K.A., Kakkar, R. and McNally, E.M. (2004) The dystrophin glycoprotein complex: signaling strength and integrity for the sarcolemma. Circ. Res., 94, 1023-1031.
4. Cooper, S.T. and Head, S.I. (2015) Membrane injury and repair in the muscular dystrophies. Neuroscientist, 21, 653-668.
5. McNeil, P.L. and Baker, M.M. (2001) Cell surface events during resealing visualized by scanning-electron microscopy. Cell Tissue Res., 304, 141-146.
6. McNeil, P.L. and Kirchhausen, T. (2005) An emergency response team for membrane repair. Nat. Rev. Mol. Cell Biol., 6, 499-505.
7. Lennon, N.J., Kho, A., Bacskai, B.J., Perlmutter, S.L., Hyman, B. T. and Brown, R.H. Jr (2003) Dysferlin interacts with annexins A1 and A2 and mediates sarcolemmal wound-healing. J. Biol. Chem., 278, 50466-50473.
8. Glover, L. and Brown, R.H. Jr (2007) Dysferlin in membrane trafficking and patch repair. Traffic, 8, 785-794.
9. Han, R. and Campbell, K.P. (2007) Dysferlin and muscle membrane repair. Curr. Opin. Cell Biol., 19, 409-416.
10. Bolduc, V., Marlow, G., Boycott, K.M., Saleki, K., Inoue, H., Kroon, J., Itakura, M., Robitaille, Y., Parent, L., Baas, F. et al. (2010) Recessive mutations in the putative calcium-activated chloride channel Anoctamin 5 cause proximal LGMD2L and distal MMD3 muscular dystrophies. Am. J. Hum. Genet., 86, 213-221.
11. Hicks, D., Sarkozy, A., Muelas, N., Koehler, K., Huebner, A., Hudson, G., Chinnery, P.F., Barresi, R., Eagle, M., Polvikoski, T. et al. (2011) A founder mutation in Anoctamin 5 is a major cause of limb-girdle muscular dystrophy. Brain, 134, 171-182.
12. Bouquet, F., Cossee, M., Behin, A., Deburgrave, N., Romero, N., Leturcq, F. and Eymard, B. (2012) Miyoshi-like distal myopathy with mutations in anoctamin 5 gene. Rev. Neurol. (Paris), 168, 135-141.
13. Penttila, S., Palmio, J., Suominen, T., Raheem, O., Evila, A., Muelas Gomez, N., Tasca, G., Waddell, L.B., Clarke, N.F., Barboi, A. et al. (2012) Eight new mutations and the expanding phenotype variability in muscular dystrophy caused by ANO5. Neurology, 78, 897-903.
14. Hartzell, H.C., Yu, K., Xiao, Q., Chien, L.T. and Qu, Z. (2009) Anoctamin/TMEM16 family members are Ca2+-activated Clchannels. J. Physiol., 587, 2127-2139.
15. Pedemonte, N. and Galietta, L.J. (2014) Structure and function of TMEM16 proteins (anoctamins). Physiol. Rev., 94, 419-459.
16. Picollo, A., Malvezzi, M. and Accardi, A. (2015) TMEM16 proteins: unknown structure and confusing functions. J. Mol. Biol., 427, 94-105.
17. Suzuki, J., Umeda, M., Sims, P.J. and Nagata, S. (2010) Calciumdependent phospholipid scrambling by TMEM16F. Nature, 468, 834-838.
18. Malvezzi, M., Chalat, M., Janjusevic, R., Picollo, A., Terashima, H., Menon, A.K. and Accardi, A. (2013) Ca2+-dependent phospholipid scrambling by a reconstituted TMEM16 ion channel. Nat. Commun., 4, 2367.
19. Brunner, J.D., Lim, N.K., Schenck, S., Duerst, A. and Dutzler, R. (2014) X-ray structure of a calcium-activated TMEM16 lipid scramblase. Nature, 516, 207-212.
20. Yu, K., Whitlock, J.M., Lee, K., Ortlund, E.A., Yuan Cui, Y. and Hartzell, H.C. (2015) Identification of a lipid scrambling domain in ANO6/TMEM16F. Elife, 4, e06901.
21. Tran, T.T., Tobiume, K., Hirono, C., Fujimoto, S., Mizuta, K., Kubozono, K., Inoue, H., Itakura, M., Sugita, M. and Kamata, N. (2014) TMEM16E (GDD1) exhibits protein instability and distinct characteristics in chloride channel/pore forming ability. J. Cell Physiol., 229, 181-190.
22. Suzuki, J., Fujii, T., Imao, T., Ishihara, K., Kuba, H. and Nagata, S. (2013) Calcium-dependent phospholipid scramblase activity of TMEM16 protein family members. J. Biol. Chem., 288, 13305-13316.
23. Mizuta, K., Tsutsumi, S., Inoue, H., Sakamoto, Y., Miyatake, K., Miyawaki, K., Noji, S., Kamata, N. and Itakura, M. (2007) Molecular characterization of GDD1/TMEM16E, the gene product responsible for autosomal dominant gnathodiaphyseal dysplasia. Biochem. Biophys. Res. Commun., 357, 126-132.
24. Testa, G., Schaft, J., van der Hoeven, F., Glaser, S., Anastassiadis, K., Zhang, Y., Hermann, T., Stremmel, W. and Stewart, A. F. (2004) A reliable lacZ expression reporter cassette for multipurpose, knockout-first alleles. Genesis, 38, 151-158.
25. Skarnes, W.C., Rosen, B., West, A.P., Koutsourakis, M., Bushell, W., Iyer, V., Mujica, A.O., Thomas, M., Harrow, J., Cox, T. et al. (2011) A conditional knockout resource for the genome-wide study of mouse gene function. Nature, 474, 337-342.
26. Gyobu, S., Miyata, H., Ikawa, M., Yamazaki, D., Takeshima, H., Suzuki, J. and Nagata, S. (2015) A role of TMEM16E carrying a scrambling domain in sperm motility. Mol. Cell Biol., 36, 645-659.
27. Zhao, P., Torcaso, A., Mariano, A., Xu, L., Mohsin, S., Zhao, L. and Han, R. (2014) Anoctamin 6 regulates C2C12 myoblast proliferation. PLoS One, 9, e92749.
28. Liewluck, T., Winder, T.L., Dimberg, E.L., Crum, B.A., Heppelmann, C.J., Wang, Y., Bergen, H.R. III and Milone, M. (2013) ANO5-muscular dystrophy: clinical, pathological and molecular findings. Eur. J. Neurol., 20, 1383-1389.
29. Milone, M., Liewluck, T., Winder, T.L. and Pianosi, P.T. (2012) Amyloidosis and exercise intolerance in ANO5 muscular dystrophy. Neuromuscul. Disord., 22, 13-15.
30. Pavlovicova, M., Novotova, M. and Zahradnik, I. (2003) Structure and composition of tubular aggregates of skeletal muscle fibres. Gen. Physiol. Biophys., 22, 425-440.
31. Agbulut, O., Destombes, J., Thiesson, D. and Butler-Browne, G. (2000) Age-related appearance of tubular aggregates in the skeletal muscle of almost all male inbred mice. Histochem. Cell Biol., 114, 477-481.
32. Abmayr, S.M. and Pavlath, G.K. (2012) Myoblast fusion: lessons from flies and mice. Development, 139, 641-656.
33. McDade, J.R., Archambeau, A. and Michele, D.E. (2014) Rapid actin-cytoskeleton-dependent recruitment of plasma membrane-derived dysferlin at wounds is critical for muscle membrane repair. FASEB J., 28, 3660-3670.
34. Sondergaard, P.C., Griffin, D.A., Pozsgai, E.R., Johnson, R.W., Grose, W.E., Heller, K.N., Shontz, K.M., Montgomery, C.L., Liu, J., Clark, K.R. et al. (2015) AAV.Dysferlin overlap vectors restore function in dysferlinopathy animal models. Ann. Clin. Transl. Neurol., 2, 256-270.
35. Harris, J.B. (2003) Myotoxic phospholipases A2 and the regeneration of skeletal muscles. Toxicon, 42, 933-945.
36. Savarese, M., Di Fruscio, G., Tasca, G., Ruggiero, L., Janssens, S., De Bleecker, J., Delpech, M., Musumeci, O., Toscano, A., Angelini, C. et al. (2015) Next generation sequencing on patients with LGMD and nonspecific myopathies: findings associated with ANO5 mutations. Neuromuscul. Disord., 25, 533-541.
37. Endo, Y., Noguchi, S., Hara, Y., Hayashi, Y.K., Motomura, K., Miyatake, S., Murakami, N., Tanaka, S., Yamashita, S., Kizu, R. et al. (2015) Dominant mutations in ORAI1 cause tubular aggregate myopathy with hypocalcemia via constitutive activation of store-operated Ca(2)(+) channels. Hum. Mol. Genet., 24, 637-648.
38. Bohm, J., Chevessier, F., Maues De Paula, A., Koch, C., Attarian, S., Feger, C., Hantai, D., Laforet, P., Ghorab, K., Vallat, J. M. et al. (2013) Constitutive activation of the calcium sensor STIM1 causes tubular-aggregate myopathy. Am. J. Hum. Genet., 92, 271-278.
39. Krahn, M., Wein, N., Bartoli, M., Lostal, W., Courrier, S., Bourg-Alibert, N., Nguyen, K., Vial, C., Streichenberger, N., Labelle, V. et al. (2010) A naturally occurring human minidysferlin protein repairs sarcolemmal lesions in a mouse model of dysferlinopathy. Sci. Transl. Med., 2, 50ra69.
40. van den Eijnde, S.M., van den Hoff, M.J., Reutelingsperger, C. P., van Heerde, W.L., Henfling, M.E., Vermeij-Keers, C., Schutte, B., Borgers, M. and Ramaekers, F.C. (2001) Transient expression of phosphatidylserine at cell-cell contact areas is required for myotube formation. J. Cell Sci., 114, 3631-3642.
41. van den Eijnde, S.M., Luijsterburg, A.J., Boshart, L., De Zeeuw, C.I., van Dierendonck, J.H., Reutelingsperger, C.P. and Vermeij-Keers, C. (1997) In situ detection of apoptosis during embryogenesis with annexin V: from whole mount to ultrastructure. Cytometry, 29, 313-320.
42. Jeong, J. and Conboy, I.M. (2011) Phosphatidylserine directly and positively regulates fusion of myoblasts into myotubes. Biochem. Biophys. Res. Commun., 414, 9-13.
43. Hamoud, N., Tran, V., Croteau, L.P., Kania, A. and Cote, J.F. (2014) G-protein coupled receptor BAI3 promotes myoblast fusion in vertebrates. Proc. Natl Acad. Sci. USA, 111, 3745-3750.
44. Hochreiter-Hufford, A.E., Lee, C.S., Kinchen, J.M., Sokolowski, J.D., Arandjelovic, S., Call, J.A., Klibanov, A.L., Yan, Z., Mandell, J.W. and Ravichandran, K.S. (2013) Phosphatidylserine receptor BAI1 and apoptotic cells as new promoters of myoblast fusion. Nature, 497, 263-267.
45. Xu, J., El Refaey, M., Xu, L., Zhao, L., Gao, Y., Floyd, K., Karaze, T., Janssen, P.M. and Han, R. (2015) Genetic disruption of Ano5 in mice does not recapitulate human ANO5-deficient muscular dystrophy. Skelet. Muscle, 5, 43.
46. Rabinowitz, J.E., Rolling, F., Li, C., Conrath, H., Xiao, W., Xiao, X. and Samulski, R.J. (2002) Cross-packaging of a single adeno-associated virus (AAV) type 2 vector genome into multiple AAV serotypes enables transduction with broad specificity. J. Virol., 76, 791-801.
47. Clark, K.R., Liu, X., McGrath, J.P. and Johnson, P.R. (1999) Highly purified recombinant adeno-associated virus vectors are biologically active and free of detectable helper and wildtype viruses. Hum. Gene Ther., 10, 1031-1039.
48. Rodino-Klapac, L.R., Janssen, P.M., Montgomery, C.L., Coley, B.D., Chicoine, L.G., Clark, K.R. andMendell, J.R. (2007) A translational approach for limb vascular delivery of the micro-dystrophin gene without high volume or high pressure for treatment of Duchenne muscular dystrophy. J. Transl. Med., 5, 45.
49. Liu, M., Yue, Y., Harper, S.Q., Grange, R.W., Chamberlain, J.S. and Duan, D. (2005) Adeno-associated virus-mediated microdystrophin expression protects young mdx muscle from contraction-induced injury. Mol. Ther., 11, 245-256.
50. Hakim, C.H., Grange, R.W. and Duan, D. (2011) The passive mechanical properties of the extensor digitorum longus muscle are compromised in 2-to 20-mo-old mdx mice. J. Appl. Physiol. (1985), 110, 1656-1663.
51. Wein, N., Vulin, A., Falzarano, M.S., Szigyarto, C.A., Maiti, B., Findlay, A., Heller, K.N., Uhlen, M., Bakthavachalu, B., Messina, S. et al. (2014) Translation from a DMD exon 5 IRES results in a functional dystrophin isoform that attenuates dystrophinopathy in humans and mice. Nat. Med., 20, 992-1000.
52. Beastrom, N., Lu, H., Macke, A., Canan, B.D., Johnson, E.K., Penton, C.M., Kaspar, B.K., Rodino-Klapac, L.R., Zhou, L., Janssen, P.M. et al. (2011) mdx((5)cv) mice manifest more severe muscle dysfunction and diaphragm force deficits than do mdx Mice. Am. J. Pathol., 179, 2464-2474.
53. Rafael-Fortney, J.A., Chimanji, N.S., Schill, K.E., Martin, C.D., Murray, J.D., Ganguly, R., Stangland, J.E., Tran, T., Xu, Y., Canan, B.D. et al. (2011) Early treatment with lisinopril and spironolactone preserves cardiac and skeletal muscle in Duchenne muscular dystrophy mice. Circulation, 124, 582-588.
54. Grose, W.E., Clark, K.R., Griffin, D., Malik, V., Shontz, K.M., Montgomery, C.L., Lewis, S., Brown, R.H. Jr, Janssen, P.M., Mendell, J.R. et al. (2012) Homologous recombination mediates functional recovery of dysferlin deficiency following AAV5 gene transfer. PLoS One, 7, e39233.
55. Arnold, W.D., Porensky, P.N., McGovern, V.L., Iyer, C.C., Duque, S., Li, X., Meyer, K., Schmelzer, L., Kaspar, B.K., Kolb, S.J. et al. (2014) Electrophysiological biomarkers in spinal muscular atrophy: preclinical proof of concept. Ann. Clin. Transl. Neurol., 1, 34-44.
56. Li, J., Sung, M. and Rutkove, S.B. (2013) Electrophysiologic biomarkers for assessing disease progression and the effect of riluzole in SOD1 G93A ALS mice. PLoS One, 8, e65976.
57. Li, J., Geisbush, T.R., Rosen, G.D., Lachey, J., Mulivor, A. and Rutkove, S.B. (2014) Electrical impedance myography for the in vivo and ex vivo assessment of muscular dystrophy (mdx) mouse muscle. Muscle Nerve, 49, 829-835.
58. Bondesen, B.A., Mills, S.T., Kegley, K.M. and Pavlath, G.K. (2004) The COX-2 pathway is essential during early stages of skeletal muscle regeneration. Am. J. Physiol. Cell Physiol., 287, C475-C483.
59. Mitchell, P.O. and Pavlath, G.K. (2001) A muscle precursor celldependent pathway contributes to muscle growth after atrophy. Am. J. Physiol. Cell. Physiol., 281, C1706-C1715.
60. Rando, T.A. and Blau, H.M. (1994) Primary mouse myoblast purification, characterization, and transplantation for cellmediated gene therapy. J. Cell Biol., 125, 1275-1287.